These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 63425

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.
    Bielawiec M, Myśliwiec M, Perzanowski A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):483-8. PubMed ID: 4139068
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
    Bielawiec M, Bodzenta A, Lukjan H, Kiersnowska-Rogowska B, Kłoczko J, Myśliwiec M, Dabrowski S, Tymiński W, Czestochowska E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):223-9. PubMed ID: 2427405
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Modifications of platelet adhesiveness and aggregation ability in atherosclerotics treated with a polysulfoester of pentosan (SP-54). II].
    Cajozzo A, Citarrella P, Carreca I.
    Boll Soc Ital Cardiol; 1971; 16(3):127-34. PubMed ID: 4110181
    [No Abstract] [Full Text] [Related]

  • 8. Plasma fibrinolytic system and blood pressure in patients with hypertensive cardiovascular disease treated with reserpine and phenformin.
    Worowski K, Prokopowicz J, Gabryelewicz A.
    Haematologia (Budap); 1970; 4(3):399-403. PubMed ID: 4256949
    [No Abstract] [Full Text] [Related]

  • 9. [Effects of clofibrate on fibrinolysis and platelet adhesiveness and aggregation in patients with arteriosclerosis].
    Cajozzo A, Abbadessa V, Carreca I, Perricone R.
    Boll Soc Ital Cardiol; 1973; 18(4):361-7. PubMed ID: 4807075
    [No Abstract] [Full Text] [Related]

  • 10. Platelet adhesiveness and fibrinolytic activity in diabetes mellitus before and after therapy.
    Narang NK, Meratwal S, Jain PC.
    J Assoc Physicians India; 1991 Oct; 39(10):784. PubMed ID: 1816213
    [No Abstract] [Full Text] [Related]

  • 11. [Phenformin treatment of arteriosclerotic patients: changes induced in the plasma lipid picture. Preliminary note].
    Negri AU, Matteoli E, Zaini GF, Riva D.
    Minerva Med; 1971 Nov 24; 62(89):4405-12. PubMed ID: 5162252
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
    Marini U, Bastoni F, Gibelli A.
    Clin Ter; 1974 Oct 15; 71(1):13-31. PubMed ID: 4138995
    [No Abstract] [Full Text] [Related]

  • 15. [Effects of D-thyroxine on fibrinolysis and on platelet adhesiveness and aggregation in arteriosclerotic subjects].
    Cajozzo A, Citarrella P, Abbadessa V, Di Marco P.
    Boll Soc Ital Biol Sper; 1974 Aug 30; 50(13):984-90. PubMed ID: 4463990
    [No Abstract] [Full Text] [Related]

  • 16. [A decrease in body weight, cholesterol and blood sugar under the influence of phenformin (phenylbiguanide) in patients with cancer and atherosclerosis].
    Dil'man VM, Riabov SI, Tsyrlina EV, Kirsanov AI, Kovaleva IG.
    Vopr Onkol; 1972 Aug 30; 18(2):84-6. PubMed ID: 5012922
    [No Abstract] [Full Text] [Related]

  • 17. Fibrinolytic activity and coronary-artery disease.
    Naimi S, Proger S.
    Lancet; 1968 Jun 08; 1(7554):1250-1. PubMed ID: 4172804
    [No Abstract] [Full Text] [Related]

  • 18. The influence of some drugs on platelet aggregation and adhesion.
    Bielawiec M, Perzanowski A, Myśliwiec M.
    Acta Univ Carol Med Monogr; 1972 Jun 08; 53():211-4. PubMed ID: 4670729
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of phenformin and stanozol administration on lipid metabolism in patients with occlusive vascular diseases].
    Perzanowski A, Bielawiec M, Myśliwiec M.
    Pol Tyg Lek; 1972 Jan 31; 27(5):174-6. PubMed ID: 5010762
    [No Abstract] [Full Text] [Related]

  • 20. [Hyperaggregation effects of thrombolytic enzymes].
    Brochier M, Griguer P.
    Therapeutique; 1973 Nov 31; 49(9):565-6. PubMed ID: 4792901
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.